John P. Butler, CEO and President at Akebia Therapeutics, Inc. (AKBA), sold 91,868 shares at $0.88 ($81K) on 2023-03-01, disclosed to the SEC on 2023-03-03.
Seasonal sale ($81k) by CEO and President — this insider has traded AKBA in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.88 | 6,370 | $6K | 6.9% |
| 2 | $0.88 | 38,259 | $34K | 41.6% |
| 3 | $0.88 | 47,239 | $42K | 51.4% |
| Total | $0.88 avg | 91,868 | $81K | 100% |
| Filing → |
| AKBA | SELL | 2025-03-04 | $170K | — | Filing → |
| AKBA | SELL | 2025-02-04 | $606K | — | Filing → |
| AKBA | SELL | 2024-03-01 | $147K | — | Filing → |